AzTrials
AzTrials

Primary DysmenorrheaNCT07095725

Effect of Primary Dysmenorrhea on Muscle Activity in Young Adult Females

An observational study of Primary Dysmenorrhea, run by Cairo University at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to investigate the effect of primary dysmenorrhea on the activity of the abdominal and back muscles in young adult females. Read more about this study

Who is it for?
Ages 18 to 25 years, women only
Conditions the study is for
Primary Dysmenorrhea
What is being tested?
Record EMG maximum amplitude from rectus abdominis, erector spinae L3 level
How many people
72 participants
Where
1 siteEgypt
Study dates
1 Jul 2025to 20 Nov 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • Women only
  • No healthy volunteers
  • Adult

Study population: Young adult females with primary dysmenorrhea

Who may be able to join

  • All females clinically diagnosed with PD, as confirmed and referred by a gynecologist.
  • Age ranges from 18 to 25 years.
  • BMI ranges from 20 to 25 kg/m2 .
  • Onset of menstrual pain 6-24 months after menarche.
  • Having a regular menstrual cycle (28 ± 7 days with no intermittent bleeding).
  • Their PD symptoms will be determined according to the WaLLID questionnaire and will be classified into mild PD (1-4), moderate PD (5-7), severe PD (8-12).
  • All participants are virgins.

Who cannot join

  • Menstrual irregularity.
  • Use of antidepressant or steroid drugs.
  • Secondary dysmenorrhea.
  • Musculoskeletal problems in the abdominal region, pelvic region, or spine.
  • Surgical history involving the abdominal region, pelvic region, or spine in the last year.
  • Any psychiatric or gynecological problems.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Mahenour Esmail Shendy, Bachelor of Physical Therapy contact

01112129932

mahenour.esmail@must.edu.eg

Abdelrahman Salah Sawan, Bachelor of Physical Therapy contact

01144047770

abdelrahman.sawan@must.edu.eg

Egypt1 site, 1 recruiting
  • Misr University for Science and Technology

    Giza

    Mahenour Esmail Shendy, Bachelors of Physical Therapy, 01112129932, mahenour.esmail@must.edu.eg

    Recruiting

Other trials in Egypt

About this study

Official title: Effect of Primary Dysmenorrhea on Abdominal and Back Muscles Activity in Young Adult Females

This study aims to investigate the effect of primary dysmenorrhea on the activity of the abdominal and back muscles in young adult females.

Read the detailed description

PD is highly prevalent in females, which directly influences their quality of life, physical function and performance. A study conducted in Palestine has shown that over half of university students with dysmenorrhea tend to skip university lectures due to painful menses.

PD is commonly associated with visceral pain and various musculoskeletal symptoms, including abdominal and back pain (Yacubovich et al., 2019). This can reduce the maximum voluntary contraction of the affected muscles, compromising their ability to provide adequate support and stability (Merkle et al., 2020). Persistent pain can disrupt postural stability and balance, raising the risk of injury by compromising stability and muscle function.

Research highlights the impact of primary dysmenorrhea (PD) on muscle function, particularly in the abdominal and back muscles, contributing to pain and reduced stability. Oladosu et al. (2018) found that abdominal muscle activity precedes menstrual pain, suggesting a neuromuscular link. Similarly, Karakus et al. (2022) and Álvarez et al. (2024) reported altered activation and reduced endurance in stabilizing muscles, including the transversus abdominis, obliques, and lumbar multifidus, with muscle thinning that may impair spinal stability. These studies emphasize PD's effect on muscle function, but further research is needed to explore variations across severities and guide effective treatments.

When these weakened muscles because of dysmenorrhea are subjected to increased or sudden activity during daily living tasks, such as lifting, bending, or other physical exertions, the risk of injury to the structures they are designed to protect is significantly heightened (Escamilla et al., 2010; Polat et al., 2022).

However, to the best of the authors' knowledge, no research has yet explored the relationship of abdominal and back muscle activity patterns to PD and their variations across different severities of dysmenorrhea, which directly contributes to females' quality of life.

Understanding this association could have significant clinical implications and contribute to new knowledge that helps physical therapists determine the need for custom-designed prevention and treatment programs for females with PD. By raising awareness of the potential musculoskeletal risks associated with PD, this study emphasizes the importance of minimizing strenuous activities during menstruation to reduce muscle strain or injury, ultimately enhancing overall health and well-being during this period.

Being tested
Record EMG maximum amplitude from rectus abdominis, erector spinae L3 level
Keywords
Muscle Activity, Maximum Voluntary Contraction, EMG, Primary Dysmenorrhea

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Record EMG maximum amplitude from rectus abdominis, erector spinae L3 levelDiagnostic test

    EMG Electrode Placement and Muscle Assessment:

    Electrodes for the rectus abdominis were placed longitudinally at the umbilical level. For the erector spinae, L3 was located using a line between the posterior superior iliac crests, and electrodes were placed ~3 cm lateral to the L3 spinous process.

    Assessment:

    Rectus Abdominis: In the crook-lying position, participants performed a slow curl-up (~35-40°), holding for 10 seconds.

    Erector Spinae: In the prone position with a 10-cm pad under the abdomen, participants lifted the upper body with neutral cervical alignment for 10 seconds.

    Each test was repeated three times with 2-minute rest intervals.

Study groups in NCT07095725
Study groupRoleWhat they receive
Group A: Mild dysmenorrheaFemales with mild PD, scoring (1-4) on the WaLLID scale.
Receives: Diagnostic Test: Record EMG maximum amplitude from rectus abdominis, erector spinae L3 level
Group B: Moderate dysmenorrheaFemales with moderate PD, scoring (5-7) on the WaLLID scale.
Receives: Diagnostic Test: Record EMG maximum amplitude from rectus abdominis, erector spinae L3 level
Group C: Severe dysmenorhheaFemales with severe PD, scoring (8-12) on the WaLLID scale.
Receives: Diagnostic Test: Record EMG maximum amplitude from rectus abdominis, erector spinae L3 level

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Activity of rectus abdominis muscle

    Maximum voluntary contraction in (μV) of rectus abdominis using electromyography device (EMG)

    Measured: 3 months

  2. Activity of erector spinae muscle at L3 vertebrae Level

    Maximum voluntary contraction in (μV) of erector spinae at L3 Level using electromyography device (EMG)

    Measured: 3 Month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jul 2025
  2. Study start1 Jul 2025
  3. Primary completion20 Oct 2025 (estimated)
  4. Study completion20 Nov 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
72 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07095725
Sponsor's protocol ID
P.T.REC\012\005884
Status last verified
Jul 2025
First submitted
23 Jul 2025
Last updated
5 Aug 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Primary Dysmenorrhea, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mahenour Esmail Shendy, Bachelor of Physical Therapy (01112129932, mahenour.esmail@must.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Activity of rectus abdominis muscle (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2025; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in